S.Biomedics Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 11, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	389,512	453,470	203,202	130,376	-	-
Market Cap Growth	61.00%	123.16%	55.86%	-	-	-
Enterprise Value	400,028	456,739	206,789	133,226	-	-
Last Close Price	31450.00	37950.00	17300.00	11500.00	-	-
PS Ratio	23.63	27.40	14.80	9.95	-	-
PB Ratio	23.30	27.11	11.10	10.55	-	-
P/TBV Ratio	50.28	54.31	17.74	18.92	-	-
EV/Sales Ratio	24.27	27.60	15.06	10.16	-	-
Debt / Equity Ratio	0.79	0.73	0.77	0.97	13.33	1.78
Net Debt / Equity Ratio	0.12	-0.15	-0.53	0.11	6.16	-1.58
Net Debt / EBITDA Ratio	-0.27	0.39	2.63	-0.30	-2.85	1.91
Net Debt / FCF Ratio	-0.17	0.29	2.00	-0.17	-0.51	1.61
Asset Turnover	0.40	0.39	0.36	0.47	0.57	0.50
Inventory Turnover	3.97	4.26	2.99	3.33	5.14	6.18
Quick Ratio	1.53	1.33	2.20	1.67	0.75	3.19
Current Ratio	1.87	1.61	2.49	2.05	0.95	3.44
Return on Equity (ROE)	-41.23%	-40.30%	-37.96%	-138.29%	-195.41%	-121.47%
Return on Assets (ROA)	-14.73%	-12.15%	-8.89%	-13.30%	-11.13%	-16.13%
Return on Capital Employed (ROCE)	-33.30%	-28.90%	-16.60%	-24.70%	-30.00%	-34.00%
Earnings Yield	-2.11%	-1.79%	-3.29%	-7.92%	-	-
FCF Yield	-3.06%	-1.89%	-2.41%	-6.13%	-	-
Buyback Yield / Dilution	-3.68%	-3.22%	-5.22%	-6.97%	-0.67%	-0.42%